Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 126 | 208 | 0 | N/A | 84 |
| Cost of Goods | 94 | 110 | N/A | N/A | N/A |
| Gross Profit | 32 | 98 | N/A | N/A | N/A |
| Operating Expenses | 3,488 | 5,904 | 15,699 | 4,190 | 3,806 |
| Operating Income | -3,457 | -5,806 | -15,699 | -4,190 | -3,722 |
| Interest Expense | 68 | 70 | 7 | 47 | 107 |
| Other Income | 17 | -7,479 | -1,852 | -3,721 | -811 |
| Pre-tax Income | -3,508 | -13,355 | -17,558 | -7,958 | -4,640 |
| Net Income Continuous | -3,508 | -13,355 | -17,558 | -7,958 | -4,640 |
| Net Income Discontinuous | N/A | N/A | 0 | 354 | N/A |
| Net Income | $-3,508 | $-13,355 | $-17,558 | $-7,605 | $-4,640 |
| EPS Basic Total Ops | -400.00 | -6,093.96 | -15,750.16 | -8,073.06 | -8,529.77 |
| EPS Basic Continuous Ops | -400.00 | -6,093.96 | -15,579.37 | N/A | N/A |
| EPS Diluted Total Ops | -400.00 | -6,093.96 | -15,750.16 | -8,073.06 | -8,529.77 |
| EPS Diluted Continuous Ops | -400.00 | -6,093.96 | -15,579.37 | N/A | N/A |
| EBITDA(a) | $-3,330 | $-13,264 | $-17,304 | $-7,902 | $-4,509 |